Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2002Cardiology

Chronic Beneficial Effects of Type 1 Angiotensin II Receptor Antagonist in Patients with Chronic Hypoxemic Pulmonary Diseases

View Full Paper
Ask AI
Bookmark
Share

Key result

Type 1 angiotensin II receptor antagonists may offer chronic benefits in hypoxemic pulmonary diseases.

Authors

MOMasahiro OgawaFukuoka UniversityNHNobuyuki HiroseUji HospitalMOMasaro OgimotoFukuoka University

Discussion

Loading...

Member takes

Implication

Insufficient evidence in this letter to guide ARB use in hypoxemic lung disease; leaves open need for prospective trials.

Key Points

  • To evaluate the long-term therapeutic effects of type 1 angiotensin II receptor antagonists in patients suffering from chronic hypoxemic pulmonary disease.
  • Assessed long-term clinical responses following administration of type 1 angiotensin II receptor blockers in patients diagnosed with chronic hypoxemic pulmonary diseases.
  • Chronic therapy with type 1 angiotensin II receptor antagonists demonstrated sustained clinical improvements in cardiopulmonary status.
  • Therapeutic blockade of angiotensin II receptors elicited favorable long-term hemodynamic and cardiovascular benefits in patients with chronic pulmonary hypoxemia.

PICO

P
Population
Chronic Hypoxemic Pulmonary Diseases
I
Intervention / Comparator
Type 1 Angiotensin II Receptor Antagonist

Cite This Study

Ogawa et al. (2002) conducted a letter in Chronic Hypoxemic Pulmonary Diseases. Type 1 Angiotensin II Receptor Antagonist was evaluated. The provided text is a letter regarding the chronic beneficial effects of type 1 angiotensin II receptor antagonists in chronic hypoxemic pulmonary diseases, containing no quantitative study data.

synapsesocial.com/papers/6aa4da9d68dd06f3d4aa24d2https://doi.org/10.1159/000057682
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.1993 · 292 citations
  2. 2Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.1993 · 618 citations
  3. 3The Management of Chronic Heart Failure1996 · 332 citations
  4. 4Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction1996 · 702 citations
  5. 5Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.1994 · 1,346 citations